Computational-based drug repurposing methods in COVID-19

被引:16
作者
Masoudi-Sobhanzadeh, Yosef [1 ]
机构
[1] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran
关键词
COVID-19; Drug repurposing; In silico drug discovery;
D O I
10.34172/bi.2020.25
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
COVID-19, as a newly emerging disease, has disrupted human's different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost consuming process, drug repurposing approaches may yield to proper curing plans. However, there are some limitations in this field, which make the process a challenging one. This letter aims to introduce drug repurposing methods and the existing challenges to detect candidate drugs which may be helpful in controlling COVID-19.
引用
收藏
页码:205 / 206
页数:2
相关论文
共 5 条
[1]   Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 [J].
Elfiky, Abdo A. .
LIFE SCIENCES, 2020, 248
[2]   Trader as a new optimization algorithm predicts drug-target interactions efficiently [J].
Masoudi-Sobhanzadeh, Yosef ;
Omidi, Yadollah ;
Amanlou, Massoud ;
Masoudi-Nejad, Ali .
SCIENTIFIC REPORTS, 2019, 9 (1)
[3]   Drug databases and their contributions to drug repurposing [J].
Masoudi-Sobhanzadeh, Yosef ;
Omidi, Yadollah ;
Amanlou, Massoud ;
Masoudi-Nejad, Ali .
GENOMICS, 2020, 112 (02) :1087-1095
[4]   DrugR plus : A comprehensive relational database for drug repurposing, combination therapy, and replacement therapy [J].
Masoudi-Sobhanzadeh, Yosef ;
Omidi, Yadollah ;
Amanlou, Massoud ;
Masoudi-Nejad, Ali .
COMPUTERS IN BIOLOGY AND MEDICINE, 2019, 109 :254-262
[5]   Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 [J].
Zhou, Yadi ;
Hou, Yuan ;
Shen, Jiayu ;
Huang, Yin ;
Martin, William ;
Cheng, Feixiong .
CELL DISCOVERY, 2020, 6 (01)